15211254

Source:http://linkedlifedata.com/resource/pubmed/id/15211254

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0087111, umls-concept:C0206061, umls-concept:C0393022, umls-concept:C0439849, umls-concept:C0445223, umls-concept:C1440080, umls-concept:C1552599, umls-concept:C1704787
pubmed:issue	2 Pt 1
pubmed:dateCreated	2004-6-22
pubmed:abstractText	Rituximab is indicated for the treatment of low-grade lymphoma. Pulmonary toxicity related to rituximab is exceptional.
pubmed:language	fre
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8408032
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal..., http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine, http://linkedlifedata.com/resource/pubmed/chemical/rituximab
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0761-8425
pubmed:author	pubmed-author:BlaiveBB, pubmed-author:ChichmanianR-MRM, pubmed-author:JullienVV, pubmed-author:LemoigneFF, pubmed-author:PerrinCC, pubmed-author:PeyradeFF
pubmed:issnType	Print
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	407-10
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:15211254-Acute Disease, pubmed-meshheading:15211254-Aged, pubmed-meshheading:15211254-Anoxia, pubmed-meshheading:15211254-Anti-Inflammatory Agents, pubmed-meshheading:15211254-Antibodies, Monoclonal, pubmed-meshheading:15211254-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:15211254-Antineoplastic Agents, pubmed-meshheading:15211254-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15211254-Blood Gas Analysis, pubmed-meshheading:15211254-Combined Modality Therapy, pubmed-meshheading:15211254-Cyclophosphamide, pubmed-meshheading:15211254-Diagnosis, Differential, pubmed-meshheading:15211254-Doxorubicin, pubmed-meshheading:15211254-Female, pubmed-meshheading:15211254-Humans, pubmed-meshheading:15211254-Lung Diseases, Interstitial, pubmed-meshheading:15211254-Lymphoma, Non-Hodgkin, pubmed-meshheading:15211254-Oxygen Inhalation Therapy, pubmed-meshheading:15211254-Prednisolone, pubmed-meshheading:15211254-Prednisone, pubmed-meshheading:15211254-Pulmonary Alveoli, pubmed-meshheading:15211254-Respiratory Insufficiency, pubmed-meshheading:15211254-Tomography, X-Ray Computed, pubmed-meshheading:15211254-Treatment Outcome, pubmed-meshheading:15211254-Vincristine
pubmed:year	2004
pubmed:articleTitle	[Alveolar hypoxemic interstitial pneumonia related to rituximab therapy].
pubmed:affiliation	Service de Pneumologie, Hôpital Pasteur, CHU de Nice, France.
pubmed:publicationType	Journal Article, English Abstract, Case Reports